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INTRODUCTION
Inflam m ation, a localized response to tissue 
in jury, and d iso rde rs  charac te rized  by 
inflam m ation are d ifficu lt problem s in clinical 
m edicine. This d ifficu lty stem s in large part from 
incom p le te  unde rs tand ing  of in flam m atory 
p rocesses and th e ir regu la tion . Recent 
developm ent of the knowledge of the role of the 
centra l nervous system  and neuroendocrine 
system  in the host responses has provided a new 
view  of the capacity of neuronal and soluble 
m ed ia to rs  in these  system s to in fluence 
inflam m ation. One of these mediators is the 
endogenous neuropeptide a-M SH, which is an 
N -acety l tr idecapep tide  derived  from  the 
cleavage of a larger precursor molecule, pro­
op iom e lan oco rtin  (PO M C ). It w as orig ina lly  
isolated and characterized from the intermediate 
lobe of the pitu itary and it was first recognized by 
its e ffec t on sk in  m e lanophores  in low er 
vertebrates ( 1 ).
a-M SH  is w idely d istributed in tissues of higher 
organism s; it has been identified in the pituitary, 
various brain regions, skin, circulation and other 
sites (2). The plasm a half-life of a-M SH is 20-25 
min in hum ans; but its biological half-life is 
unknown (3). It has been shown that plasma and 
local a-M SH  concentrations increase in certain 
in flam m atory d isorders and stress (2,4). Despite
its s im ila rity  in peptide  s tructu re  to 
adrenocorticotropic horm one (ACTH), a-M SH 
has no m ajor in fluence on g lococortico id  
secretion (5).
Binding sites for the peptide are w idespread and 
a-M SH receptors have been characterized and 
cloned in various tissues (6,7). The receptors for 
a-M SH and related m elanocortins are specific G 
pro te in -coup led  receptors  conta in ing  seven 
transm em brane helixes that activate adenylate 
cyclase. Five subtypes of melanocortin receptor 
fam ily have been recognized to date (MC-1 to 
MC-5). MC-1 receptor is the first receptor that is 
identified on im m une/in flam m atory  ce lls (8 ). 
Cultured mouse and human macrophages and 
melanocytes contain mRNA for MC-1 receptor
(9,10). MC-1, MC-3, MC-4 and MC-5 receptors 
have been in the brain tissue (11); whereas, MC- 
2  receptor is only found in the adrenal cortex
( 1 2 ). MC-1 is a lso expressed in human 
neutrophils which may account for the inhibitory 
influence of the peptide on neutrophil m igration in 
the initial phase of inflam m ation (13).
There is recent evidence that murine mast cell 
line expresses mRNA for MC-1 receptor and that 
a-M SH  m odulates m ast cell responsiveness
(14). In these experim ents , it has been 
suggested that a-M SH may exert an inhibitory 
effect on the mast cell-dependent com ponent of
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a spec ific  in flam m ato ry  response w hich is 
characte rized  by the re lease of cy tok ines, 
chem okines and chem ical m ediators including 
histam ine and prostaglandins.
Anti-inflammatory Effects of a-MSH in 
Animal Models
In add ition  to its w e ll-know n  e ffect on 
p igm enta tion , a -M S H  a lso m ed ia tes o ther 
biologic functions such as control of inflam m ation 
and fever (15). The an ti- in flam m ato ry  and 
antipyretic effects of the peptide are associated 
with the C O O H-term lnal tripeptide sequence, 
Lys-Pro-Val (a-M SH [11-13]) (16) (Fig.1). a-M SH 
has anti-inflam m atory effects in all of the major 
forms of inflam m ation: acute, chronic, system ic, 
a lle rg ic  and cen tra l ne rvous system  (CNS) 
in flam m ations. The ev idence  of the  potent 
influence of a-M SH  on acute inflam m ation are 
m ostly de rived  from  expe rim en ts  in which 
in flam m ation  w as caused by in jection  of 
exogenous in flam m ato ry  agents. Recent 
ev idence of an ti- in flam m ato ry  e ffec t of the 
peptide has been obtained from the experim ents 
in w hich m ice w ere p re trea ted  w ith  
C o ry n e b a c te riu m  P a rv u m  o r bacteria l 
lipopolysaccharide (LPS), a regimen that results 
in severe hepatitis (17). In this study, a-MSH 
prevents hepatic in jury and increase of plasm a 
nitrate / nitrite levels. It also decreases LPS- 
Induced cytokine (TNF-a) and chem okine (IL-8 ) 
mRNA accum ulation and neutrophil infiltration 
even when it is adm inistered 30 min after LPS 
challenge (17).
R ecent obse rva tions  on de layed  type 
hypersensitiv ity reactions indicate that a-MSH 
inhibits induction of contact hypersensitiv ity and 
leads to hapten-specific to lerance (18). These 
effects of a-M SH  are presum ed to involve an IL- 
1 0  "an ti- in flam m ato ry  cy tok ine " in te rm ed ia te  
because trea tm en t w ith  the IL-10 an tibody 
reduces the effects of the peptide (18).
a -M S H  p reven ts  deve lop m e n t of ch ron ic  
inflam m ation by inhibiting ce llu lar infiltration in a 
rat model of m ycobacterium -induced arthritis
(19). It im proves several aspects of system ic 
in flam m ato ry  response  syndrom e, inc lud ing  
white blood cell m igration into the lungs after 
endotox in 'in fus ion  (20). In addition, it increases 
survival in experim enta l peritonitis / endotoxem ia 
in the rats (2 0 ).
The peptide prom otes functional recovery in CNS 
ischem ia/reperfusion. Recent evidence indicates 
that a-M SH m odulates production of TN F-a  in 
the brain tissue of m ice follow ing central LPS 
injection (21). From these observations, it is clear 
that the peptide is e ffective in in flam m atory 
processes that occur in w idespread regions of 
the body.
It is a lso rem arkab le  tha t the peptide  
concentration increases in various clin ical and 
experim enta l in flam m ato ry  d iso rde rs . The 
concentration of a-M SH has been determ ined in 
synovial tissues and synovia l fluid of patients with 
rheum ato id  a rth ritis , m yocard ia l in fa rc tion , 
endo toxem ia  or H IV in fec tion . Peptide 
concentration ranged from 10 ' 1 0  and 10 - 8  M in 
these pathological conditions (22-25).
POMC
T
ACTH
a-MSH
1 4  8 11 13
(Ser Tyr Ser Met Glu His Phe Arg Trp Gly Lys Pro Val)
Mechanisms of the Peripheral Effects 
of a-MSH
The neuropeptide a-M SH  is im portant to the 
natural lim itation of fever, which is an early host 
response to endotoxin. a-M SH  given centra lly or 
system ically reduces fever and this indicates that 
the peptide reaches the brain. During fever there 
is pulsatile release of the peptide from septal 
areas of the brain. a-M SH  given exogenously 
causes antipyresis; whereas blockade of the 
endogenous a-M SH  with antiserum  augm ents 
the febrile response to pyrogens (26).
F ig .  1 : T h e  stru c tu re  of th e  a-M S H  (1-13)
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The capac ity  o f IL-1 to e lic it a pyrogenic 
response can be effectively inhibited by central 
adm in istra tion of a -M S H  in rabbits and this 
suggests that the peptide may also be involved in 
the actions of IL-1 (27). This peptide is antipyretic 
w hen g iven cen tra lly , in travenously  or 
intragastrically. It is 25,000 tim es more potent 
than acetam inophen, as an antagonist of IL-1 
induced fever when given centra lly and 2 0 , 0 0 0  
tim es more potent when given intravenously (28). 
Robertson et al. dem onstrated that intravenous 
injection of a-M SH  abrogates fever, neutrophilia 
and elevation of hepatic serum amyloid protein 
followed by injection of IL-1 (29). In contrast, 
ACTH is unable to b lock e ither the neutrophilia or 
the serum  am yloid protein elevation seen in 
response to IL-1, but it reduces fever by 67% 
(29). It has been indicated that the antipyretic 
action of ACTH is not related to glucocorticoid 
release because ACTH effectively reduces fever 
in adrenalectom ized rabbits (30). Thus, these 
data indicate that both ACTH and a-M SH may 
serve as regulators of IL-1 related responses in  
vivo.
In addition to its action w ithin the brain to reduce 
fever, a-M SH  inhibits proinflam m atory cytokine 
(e.g., IL - ip ,  IL -6 , IFN-y and TN F-a)- or 
chem oa ttrac tive  chem ok ine  (e.g., IL-8 )-
dependent reactions both in  v itro  and in  vivo. For 
exam ple, it inhibits TN F-a  production by human 
m ononuc lear ce lls  and IFN-y production by 
antigen-stim ulated murine lymph node cells and 
peripheral blood m onocytes (31,32). It down- 
regulates the production of IFN-y by human T 
cells and m odulates IgE synthesis by human B 
cells (33). It has been shown that it completely 
abolishes mRNA expression for IL-8 , TNF-a, and 
m onocyte  ch e m oa ttrac ta n t p ro te in - 1  in 
endotoxin-induced liver inflam m aton (17). It also 
inhibits the activation of NF-kB which is an 
im portant factor for the induced transcription of 
T N F-a  (34).
A lthough the m echanism  is not clear, it has been 
show n tha t a -M S H  dow n-m odu la tes  the 
transcription of IL-1 [3, T N F -a  but not those of IL- 
4 and IL-6 . Cannon et al. found that a-M SH 
inh ib its  IL -1 -induced  m urine thym ocyte  
proliferation and fibroblast PGE production in  
v itro  (35). Moreover, the peptide and its 
analog N le4-d-Phe7-M SH block responses to 
IL-1 in  vivo, but not thym ocyte proliferation
or PGE production stimulated by IL-1 in  vitro  
(36).
P revious stud ies have shown tha t a-M SH  
prevents acute inflammation after intradermal 
injection of LPS, cytokines or irritants including 
carrageenan and picryl chloride. It prevents LPS- 
induced liver dam age even when it is 
adm inistered 30 min after LPS (17). It also 
inhibits IL-1 -, TNF-a-, or pyrogen-induced edema 
in  vivo  (37). It has shown that plasma a-MSH 
concentration increases within 1 h follow ing the 
peripheral adm inistration of endogenous pyrogen 
and this suggests that the peptide is important in 
the early phase of host defense (38).
System ic adm in istration of the peptide also 
reduces som e b io log ica l responses of the 
cytokines and inhibits neutrophil m igration both in 
vitro  and in  vivo. It has been dem onstrated that 
chem otactic m igration of human neutrophils in IL- 
8  and N -fo rm yl-m eth ion l-leucy l-pheny la lan ine  
(fMLP) gradients was inhibited by a-M SH in a 
dose-re la ted  fash ion (13). Th is e ffect is 
presum ably the result of stim ulation of MC-1 
receptors expressed by neutrophils. However, 
unlike m urine and hum an m acrophages, 
neutrophils are unable to produce either the 
POMC-the precursor of a-M SH - or the peptide 
itself. Any influence of a-M SH on neutrophils 
would therefore occur through its paracrine or 
endocrine actions (F ig.2).
More recently, it has been dem onstrated that a- 
MSH inhibits the production of nitric oxide (NO) 
which is considered as a potent inflammatory 
agent produced in large amounts by monocytic
F ig .2  s The mechanisms of the effect of a-MSH on 
macrophages and neutrophils. (Modified from Lipton 
JM et al. Immunol Today 1997;18:140-145).
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cells, particularly m urine m acrophages. a-M SH 
stim u la tes cAM P production  and inh ib its  
LPS/cytokine-stim ulated NO and inducible NO 
synthase (NOS) production in murine and human 
m acrophages (9). These cells have mRNA both 
for the MC-1 receptor and POMC and they 
secrete a-M SH when stim ulated with TNF-a. a- 
MSH inhibits LPS-induced increases in serum 
nitrate/nitrite in both LPS and C. P a rvu m /LPS- 
induced liver injury m odels (17). It also prevents 
the induction of i NOS after renal ischem ia in 
mice and rats (39). Recently, we and other 
investigators have shown that a-M SH has a 
protective effect on co lonic lesions in a rat model 
of experim ental colitis through the inhibition of 
NO (40). Rajora et al has dem onstrated that a- 
MSH treatm ent sign ificantly inhibits increased 
colonic nitrite va lues and T N F-a  production in 
dextran sulfate sodium -induced colitis in mice 
(41). S im ilarly, a-M SH  has been found to reduce 
the production of NO and T N F -a  by cultured 
m urine m icrog lia  s tim u la ted  w ith  p-am ylo id  
protein in  v itro  (42).
Mechanisms of fhe Central Effects of 
a-MSH
In addition to its actions w ith in the brain to reduce 
fever, it is likew ise clear that a-M SH can act 
cen tra lly  to inh ib it pe riphera l in flam m ation  
induced by local application of irritants. For 
example, in the observations of m ice with picryl 
chloride induced ear inflam m ation, it has been 
reported that central a-M SH  adm inistration- in 
doses that are ineffective intraperitoneally (OH­
IO pg)- reduces edem a fo rm a tion  (43). 
Subsequent studies have shown that central 
adm in is tra tion  of a -M S H  a ttenua tes  skin 
inflam m ation in m ice caused by intraderm al 
injection of the pro inflam m atory mediators such 
as IL-1P, IL-8 , LTB 4  and PAF (44). These 
observations indicate that the anti-inflam m atory 
effect of the peptide in the periphery may be 
mediated by the a-M SH  receptors in the brain.
It is clear that intact descending neural pathways 
are essential to the anti-in flam m atory action of 
centrally adm inistered a-M SH . Transection of the 
spinal cord in m ice w ith hind paw inflam m ation 
prevents the an ti-in flam m atory action of the 
centrally adm inistered peptide (45). In addition, 
intraperitoneal in jection of a-MSH in m ice with
spinal transection has a sm aller and delayed 
an ti- in flam m ato ry  e ffect. By con trast, 
adm inistration of the tripeptide a - M S H ^ .^  in the 
sam e model has strong and rapid influence on 
inflam m ation (45). These observations suggest 
that the tripeptide a -M S H !i_ i3  can act d irectly in 
the periphery to inhibit in flam m ation whereas, a- 
M SH i _i 3  presum ably requires the activation of 
descend ing  inh ib ito ry  pa thw ays fo r fu ll 
expression of its anti-in flam m atory effect.
Centra lly adm inistered a-M SH  must therefore 
m ediate its anti-in flam m atory effects through 
activation of neural pathways that require specific 
neurotransm itte rs. In the m ouse ear edem a 
model, nonspecific b lockade of the (3-adrenergic 
recep to rs  or spec ific  b lockade  of the (32  - 
receptors in the periphery inh ib its  the an ti­
inflam m atory effect of centra lly adm inistered a- 
MSH (45). However, b lockade of cholinerg ic 
(m uscarinic) receptors or a- or ($1 -adrenergic 
receptors has no effect (45). These results 
suggest tha t pe riphera l p2 -ad rene rg ic  
neurotransm ission is essential to the effect of 
central a-M SH  on periphera l inflam m ation.
W ith regard to changes in the periphera l site of 
inflam m ation caused by the centra l a-M SH , it is 
possible that a-M SH  can inhibit local neurogenic 
com ponents of the in flam m atory response. That 
is, the stim ulation of the centra l MC receptors by 
the pep tide  may m odu la te  the re lease of 
neurogen ic  in flam m ato ry  m ed ia to rs  (e.g., 
substance P or calcitonin gene-re la ted peptide) 
at the site of in jury after transm ission of inhibitory 
s igna ls  in the descend ing  an ti- in flam m ato ry  
pa thw ays w h ich  requ ire  the p resence  of 
peripheral P2- adrenerg ic receptors.
CONCLUSION
The evidence sited above indicates that a-M SH 
has potent and broad anti-in flam m atory effects in 
m any fo rm s of in flam m ation . The a n ti­
in flam m atory actions of the peptide through the 
ac tiva tion  of cen tra l and /o r pe riphera l 
m elanocortin receptors m ight be useful in the 
treatm ent of som e clin ical cases in the future. 
Low toxicity of the peptide in anim als, its brief 
duration of action and the lack of evidence of 
to lerance to repeated adm in is tra tion  support 
further investigations on the peptide.
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